NCT00078637View on ClinicalTrials.gov

Dosing and Safety Study of E7820 in Patients With a Malignant Solid Tumor or Lymphoma

PHASE1CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

August 31, 2006

Study Completion Date

February 28, 2007

Conditions
NeoplasmsLymphoma, Malignant
Interventions
DRUG

E7820

Trial Locations (1)

Unknown

San Antonio

All Listed Sponsors
lead

Eisai Inc.

INDUSTRY

NCT00078637 - Dosing and Safety Study of E7820 in Patients With a Malignant Solid Tumor or Lymphoma | Biotech Hunter | Biotech Hunter